Nanotech https://www.bioworld.com/rss en-us Nb20 nanobody reverses depressive-like behavior in mice http://www.bioworld.com/articles/728679 Fri, 06 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728679-nb20-nanobody-reverses-depressive-like-behavior-in-mice Microsphere injectables biotech G2Gbio debuts with $38M http://www.bioworld.com/articles/723474 Tue, 19 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/723474-microsphere-injectables-biotech-g2gbio-debuts-with-38m G2Gbio CEO Lee Hee-yong (center) commemorates the company’s listing on the Korea Exchange G2Gbio EO Lee Hee-yong (center) commemorates the company’s listing on the Korea Exchange Aug. 14. Credit: KRX Microsphere injectables biotech G2Gbio debuts with $38M http://www.bioworld.com/articles/723034 Thu, 14 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/723034-microsphere-injectables-biotech-g2gbio-debuts-with-38m G2Gbio CEO Lee Hee-yong (center) commemorates the company’s listing on the Korea Exchange G2Gbio EO Lee Hee-yong (center) commemorates the company’s listing on the Korea Exchange Aug. 14. Credit: KRX PVT-401 achieves milestone under Parvus and Abbvie inflammatory bowel disease collaboration http://www.bioworld.com/articles/719435 Tue, 22 Apr 2025 09:00:00 -0400 https://www.bioworld.com/articles/719435-pvt-401-achieves-milestone-under-parvus-and-abbvie-inflammatory-bowel-disease-collaboration Outline of intestine and person holding stomach in pain Platform tech reprograms immune responses against KRAS-mutant metastases http://www.bioworld.com/articles/719093 Thu, 10 Apr 2025 09:00:00 -0400 https://www.bioworld.com/articles/719093-platform-tech-reprograms-immune-responses-against-kras-mutant-metastases 3D pancreas illustration Chimeric nanoparticles tested in T-cell lymphomas, gastric cancer http://www.bioworld.com/articles/717231 Wed, 12 Feb 2025 09:00:00 -0500 https://www.bioworld.com/articles/717231-chimeric-nanoparticles-tested-in-t-cell-lymphomas-gastric-cancer Grifols collaborates with FcR Therapeutics on autoimmune diseases http://www.bioworld.com/articles/717035 Thu, 06 Feb 2025 09:00:00 -0500 https://www.bioworld.com/articles/717035-grifols-collaborates-with-fcr-therapeutics-on-autoimmune-diseases Cour’s CNP-103 gains IND clearance for type 1 diabetes 0.2 ng/mL.]]> http://www.bioworld.com/articles/717017 Wed, 05 Feb 2025 09:00:00 -0500 https://www.bioworld.com/articles/717017-cours-cnp-103-gains-ind-clearance-for-type-1-diabetes Illustration of pancreas, close up of islet Intravesical instillation of CRISPR-Cas13a and fenbendazole nanoparticle formulations shows synergy in bladder cancer model http://www.bioworld.com/articles/711971 Thu, 29 Aug 2024 09:00:00 -0400 https://www.bioworld.com/articles/711971-intravesical-instillation-of-crispr-cas13a-and-fenbendazole-nanoparticle-formulations-shows-synergy-in-bladder-cancer-model 3D concept image of nanoparticle layers SN Bioscience nabs FDA fast track for lung cancer drug http://www.bioworld.com/articles/708605 Tue, 14 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/708605-sn-bioscience-nabs-fda-fast-track-for-lung-cancer-drug Vials of SNB-101 Credit: SN Bioscience SN Bioscience nabs FDA fast track for lung cancer drug http://www.bioworld.com/articles/708476 Fri, 10 May 2024 12:00:00 -0400 https://www.bioworld.com/articles/708476-sn-bioscience-nabs-fda-fast-track-for-lung-cancer-drug Vials of SNB-101 Credit: SN Bioscience Bispecific nanobody targeting PD-L1 and CXCR4 shows efficacy in pancreatic tumor models http://www.bioworld.com/articles/691993 Thu, 01 Dec 2022 09:00:00 -0500 https://www.bioworld.com/articles/691993-bispecific-nanobody-targeting-pd-l1-and-cxcr4-shows-efficacy-in-pancreatic-tumor-models Pancreas China’s Novamab looks into inhaled delivery of nanobody against COVID-19 http://www.bioworld.com/articles/496955 Tue, 25 Aug 2020 14:17:00 -0400 https://www.bioworld.com/articles/496955-chinas-novamab-looks-into-inhaled-delivery-of-nanobody-against-covid-19 Novamab nebulizer The nebulizer Novamab uses for its Nb11-59 therapy. China’s Novamab looks into inhaled delivery of nanobody against COVID-19 http://www.bioworld.com/articles/496837 Wed, 19 Aug 2020 12:00:00 -0400 https://www.bioworld.com/articles/496837-chinas-novamab-looks-into-inhaled-delivery-of-nanobody-against-covid-19 Novamab nebulizer The nebulizer Novamab uses for its Nb11-59 therapy. FDA works to leverage nanotech investment, better capacity for evaluation http://www.bioworld.com/articles/496712 Thu, 13 Aug 2020 13:00:00 -0400 https://www.bioworld.com/articles/496712-fda-works-to-leverage-nanotech-investment-better-capacity-for-evaluation Nanotechnology illustration